SCOPUS 정보 검색 플랫폼

Volumn 78, Issue 3 I, 2000, Pages 369-372

Phase 2 trial of liposomal doxorubicin (40 mg/m2) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum

(6) Markman, Maurie a Kennedy, Alexander a Webster, Kenneth a Peterson, Gertrude a Kulp, Barbara a Belinson, Jerome a

a TAUSSIG CANCER INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PACLITAXEL; PLATINUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG TOLERABILITY; FEMALE; HUMAN; OVARY CANCER; PERITONEUM CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN TOXICITY; STOMATITIS; TREATMENT OUTCOME; UTERINE TUBE CARCINOMA;

EID: 0033813383 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2000.5921 Document Type: Article

Times cited : (161)

References (16)

1
- 0030054309
- Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
- (1996) N Engl J Med , vol.334 , pp. 1-6
- McGuire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.E.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷ Davidson, M.⁸

2
- 0025861545
- Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: A meta-analysis
- (1991) J Clin Oncol , vol.9 , pp. 1668-1674

3
- 0028948614
- Impact of doxorubicin on survival in advanced ovarian cancer
- (1995) J Clin Oncol , vol.13 , pp. 726-732
- A'Hern, R.P.¹ Gore, M.E.²

4
- 0026679287
- Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma
- (1992) Obstet Gynecol , vol.80 , pp. 954-960
- Fanning, J.¹ Bennett, T.Z.² Hilgers, R.D.³

5
- 0030017681
- Twelve-year follow-up of a randomized trial comparing cisplatin and cyclophosphamide with cisplatin, doxorubicin and cyclophosphamide in patients with advanced epithelial ovarian cancer
- (1996) Int J Gynecol Cancer , vol.6 , pp. 286-290
- Gadducci, A.¹ Bruzzone, M.² Carnino, F.³ Ragni, N.⁴ Rubagotti, A.⁵ Conte, P.F.⁶

6
- 0027382941
- Cancer of the ovary
- (1993) N Engl J Med , vol.329 , pp. 1550-1559
- Cannistra, S.A.¹

7
- 0032563825
- Doxorubicin-induced cardiomyopathy
- N Engl J Med , vol.339 , pp. 900-905
- Singal, P.K.¹ Iliskovic, N.²

8
- 0029038996
- Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies
- (1995) J Clin Oncol , vol.13 , pp. 1777-1785
- Uziely, B.¹ Jeffers, S.² Isacson, R.³ Kutsch, K.⁴ Wei-Tsao, D.⁵ Yehoshua, Z.⁶ Libson, E.⁷ Muggia, F.M.⁸ Gabizon, A.⁹

9
- 0028853611
- Lack of vesicant injury following extravasation of liposomal doxorubicin
- (1995) J Natl Cancer Inst , vol.87 , pp. 1556-1557
- Madhavan, S.¹ Northfelt, D.W.²

10
- 0031055830
- Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation
- (1997) J Clin Oncol , vol.15 , pp. 987-993
- Muggia, F.M.¹ Hainsworth, J.D.² Jeffers, S.³ Miller, P.⁴ Groshen, S.⁵ Tan, M.⁶ Roman, L.⁷ Uziely, B.⁸ Muderspach, L.⁹ Garcia, A.¹⁰ Burnett, A.¹¹ Greco, F.A.¹² Morrow, C.P.¹³ Paradiso, L.J.¹⁴ Liang, L.-J.¹⁵

11
- 0001658449
- Doxil (Doxorubicin HCL liposome injection) in the treatment of patients with refractory advanced epithelial ovarian carcinoma - Results of an interim analysis
- (1998) Proc Am Soc Clin Oncol , vol.17
- Gordon, A.N.¹ Hainsworth, J.² Moore, M.³ Weissman, C.⁴ Malfetano, J.⁵ Wolin, E.⁶ Kosty, M.⁷ Peters, W.A.⁸ Granai, C.O.⁹ Lopez, A.M.¹⁰ Malviya, V.¹¹ Rose, P.¹² Rosales, R.¹³ Teitelbaum, A.H.¹⁴

12
- 0000115904
- Interim analysis of a non-comparative, multicenter study of Doxil/Caelyx in the treatment of patients with refractory ovarian cancer
- (1999) Proc Am Soc Clin Oncol , vol.18
- Rose, P.¹ Gordon, A.N.² Granai, C.O.³ Hainsworth, J.⁴ Weissman, C.⁵ Lopez, A.M.⁶ Kosty, M.⁷ Peters, W.A.⁸ Malfetano, J.⁹ Malviya, V.¹⁰ Del Prete, S.A.¹¹ Moore, M.¹² Wolin, E.¹³ Goldberg, D.¹⁴ Feherenbacher, L.¹⁵ Yee, S.J.¹⁶ Orr, J.¹⁷ Garfield, D.¹⁸ Rosales, R.¹⁹ Shapington, T.²⁰ more..

13
- 0027101782
- Phase I trial of intraperitoneal taxol: A Gynecologic Oncology Group study
- (1992) J Clin Oncol , vol.10 , pp. 1485-1491
- Markman, M.¹ Rowinsky, E.² Hakes, T.³ Reichman, B.⁴ Jones, W.⁵ Lewis J.L., Jr.⁶ Rubin, S.⁷ Curtin, J.⁸ Barakat, R.⁹ Phillips, M.¹⁰ Hurowitz, L.¹¹ Almadrones, L.¹² Hoskins, W.¹³

14
- 0028862180
- Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: A Gynecologic Oncology Group pilot study
- (1995) J Clin Oncol , vol.13 , pp. 2961-2967
- Francis, P.¹ Rowinsky, E.² Schneider, J.³ Hakes, T.⁴ Hoskins, W.⁵ Markman, M.⁶

15
- 0032144047
- Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent
- (1998) Gynecol Oncol , vol.70 , pp. 272-274
- Markman, M.¹ Kennedy, A.² Sutton, G.³ Hurteau, J.⁴ Webster, K.⁵ Peterson, G.⁶ Kulp, B.⁷ Belinson, J.⁸

16
- 0003200056
- A retrospective analysis of the clinical utility of doxil in recurrent ovarian cancer (ROC)
- (1999) Proc Am Soc Clin Oncol , vol.18
- Campos, S.M.¹ Penson, R.T.² MacNeill, K.M.³ Berkowitz, R.S.⁴ Cook, S.E.⁵ Fuller, A.F.⁶ Goodman, A.K.⁷ Nikrui, N.⁸ Shulman, L.N.⁹ Matulonis, U.A.¹⁰ Seiden, M.V.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.